Intuitive Surgical (NASDAQ:ISRG – Get Free Report) had its price objective lifted by investment analysts at Barclays from $610.00 to $674.00 in a report released on Monday. Barclays‘s price target would suggest a potential upside of 17.39% from the company’s current price.
A number of other research analysts have also recently commented on the stock. BTIG Research upped their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research report on Tuesday, November 26th. Robert W. Baird upped their price objective on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a report on Thursday, October 17th. Evercore ISI reiterated a “cautious” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Piper Sandler restated an “overweight” rating and set a $670.00 price target (up from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Finally, Raymond James lifted their price objective on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $613.10.
View Our Latest Research Report on ISRG
Intuitive Surgical Stock Up 0.1 %
Insider Activity at Intuitive Surgical
In related news, insider Jamie Samath sold 22,903 shares of the business’s stock in a transaction on Friday, November 8th. The shares were sold at an average price of $525.00, for a total value of $12,024,075.00. Following the completion of the sale, the insider now directly owns 8,757 shares of the company’s stock, valued at $4,597,425. The trade was a 72.34 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now directly owns 12,275 shares in the company, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 28,749 shares of company stock valued at $15,303,875 over the last three months. 0.90% of the stock is owned by corporate insiders.
Hedge Funds Weigh In On Intuitive Surgical
Hedge funds have recently modified their holdings of the business. Bennett Selby Investments LP grew its position in Intuitive Surgical by 3.9% during the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock worth $234,000 after purchasing an additional 17 shares during the last quarter. LVW Advisors LLC grew its holdings in shares of Intuitive Surgical by 1.3% during the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock worth $756,000 after buying an additional 19 shares during the last quarter. Wesbanco Bank Inc. increased its position in Intuitive Surgical by 1.6% in the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock valued at $635,000 after acquiring an additional 19 shares during the period. FSM Wealth Advisors LLC raised its stake in Intuitive Surgical by 3.7% during the 4th quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider’s stock valued at $275,000 after acquiring an additional 19 shares during the last quarter. Finally, Journey Strategic Wealth LLC lifted its position in Intuitive Surgical by 1.9% during the 4th quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider’s stock worth $542,000 after acquiring an additional 19 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Articles
- Five stocks we like better than Intuitive Surgical
- What does consumer price index measure?
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- The Basics of Support and Resistance
- What Does the Future Hold for Eli Lilly?
- Trading Stocks: RSI and Why it’s Useful
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.